Nootropic and mood peptide research
Everything on this page describes laboratory research. Compounds named here are supplied for in-vitro and analytical work by verified researchers only. None is a registered medicine in South Africa, none is approved for human or veterinary use, and nothing on this page is guidance for use in a person.
This area covers peptides studied for their interaction with signalling in the central nervous system: expression of the neurotrophins that govern neuronal survival, turnover in the monoamine systems associated with mood and attention, and the synaptic plasticity that underlies learning in animal models. A large share of the foundational work sits in Russian-language literature that is unevenly indexed in the databases Western reviews draw on, which is a real constraint on how settled any of it can be called.



What the research measures
Neurotrophin expression
Monoamine turnover
Synaptic plasticity
Behavioural models
Compounds studied in this area
Semax
Met-Glu-His-Phe-Pro-Gly-Pro
A synthetic heptapeptide built from a fragment of adrenocorticotropic hormone with a proline-glycine-proline tail added at the carboxyl end. That tail is the whole point of the modification: it slows enzymatic breakdown substantially compared with the unmodified fragment, which is very short-lived in plasma.
Published work examines brain-derived neurotrophic factor expression, dopaminergic and serotonergic turnover in rodent brain tissue, and outcomes in ischaemia models. Much of the clinical literature on it is Russian-language and poorly indexed, so the evidence base is at once larger than a database search suggests and harder to appraise.
Selank
Thr-Lys-Pro-Arg-Pro-Gly-Pro
A synthetic heptapeptide derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide, carrying the same proline-glycine-proline extension used to resist enzymatic degradation.
Research centres on GABAergic and serotonergic signalling, on hippocampal expression of brain-derived neurotrophic factor, and on anxiety paradigms in rodents. Its tuftsin origin means part of the literature examines immune signalling alongside the behavioural endpoints, and how those two strands relate is unresolved.
Dihexa
N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
An analogue of angiotensin IV, modified to resist peptidase activity and to cross the blood-brain barrier more readily than the parent peptide. It sits closer to a small molecule than to a conventional peptide.
Work focuses on hepatocyte growth factor and its receptor c-Met, and on dendritic spine formation in cultured hippocampal neurons. The published body is small and comes largely from one research group, which is a material limitation: independent replication is what would move it, and there is little of it.
Laboratory handling and storage
Lyophilised peptide is the stable form. It is normally held below freezing and protected from light.
Short peptides of this class are degraded quickly by peptidases once in solution, which is why the literature reports working solutions prepared close to the point of use rather than held.
Repeated freeze and thaw cycles degrade peptide integrity, so single-use aliquots are the standard practice.
Handling, reconstitution and disposal are laboratory procedures and should follow the receiving facility's own written procedures and local regulations.
